Global Erythropoietin Drugs MarketPosted by NISHA SHAHA on February 11th, 2022 The report \"Global Erythropoietin Drugs Market, by Drug Class (Biologics and Biosimilar), by Product (Epoetin-Alfa, Epoetin-Beta, Darbepoetin-Alfa, and Others (Pegylated Erythropoietin and Carbamylated Erythropoietin)), by Application (Cancer, Hematology, Renal diseases, and Neurology), and Region - Global Forecast to 2029\" The Global Erythropoietin Drugs Market accounted for US$ 11 billion in 2020 and is estimated to be US$ 25.9 billion by 2030 and is anticipated to register a CAGR of 8.9%. This is attributed to increasing prevalence of anemia, caner, chronic kidney disease, bone marrow dysfunction, and HIV, coupled with rising incidences of deficiency of iron, vitamin B12, and folic acid due to desk-bound lifestyle. Key Highlights:
Key Market Insights from the report: The Global Erythropoietin Drugs Market accounted for US$ 11 billion in 2020 and is estimated to be US$ 25.9 billion by 2030 and is anticipated to register a CAGR of 8.9%.The market report has been segmented on the basis of drug class, product, application, and region.
To know the upcoming trends and insights prevalent in this market, click the link below: Links https://www.prophecymarketinsights.com/market_insight/Global-Erythropoietin-Drugs-Market-By-808 Like it? Share it!More by this author |